This one-day program at the Naomi Berrie Diabetes Center at Columbia University is designed for research scientists, clinicians and students with an interest in the latest technical innovations that may impact current and future care of patients with diabetes.
Specifically, this conference will discuss recent methodologic advances that enable more precise animal and ex vivo disease modeling (using stem cells), which coupled with integration of genomic data, should enable identification of new therapeutic targets to benefit diabetic patients. Additional focus areas will include novel insulin preparations, in vivo beta cell imaging techniques, new glucose sensors, and integrated systems that allow greater communication between glucose sensors and insulin pumps.
At the conclusion of this activity, participants will be better able to:
• Recognize modulators of insulin processing and secretion.
• Review novel methods for assessment of disease-related genomic data.
• Discuss advances in technologies for treatment of diabetes.
Saturday, November 16, 2019 at 8:00am to 3:50pm
Russ Berrie Medical Science Pavilion
1150 Saint Nicholas Avenue, New York, NY 10032